PE-backed Abbisko Therapeutics plans Hong Kong IPO – Bloomberg News

Chinese biotechnology company Abbisko Therapeutics Co. Ltd. is planning a Hong Kong IPO that could raise $250 million, Bloomberg News reported, citing people familiar with the matter.

Private equity firms Carlyle Group Inc. and Warburg Pincus LLC are among backers of Abbisko, which is working with advisers on the offering and intends to get listed as soon as this year, the people told the news outlet.

Discussions are at an early stage and size and timing of the offering could change, the people said.

In January, Abbisko raised $123 million in a series D round led by Carlyle, the report added.

An Abbisko representative did not immediately respond to the news outlet's request for comment, the report noted.